| The impact of the COVID-19 pandemic on cancer patients OM Al-Quteimat, AM Amer American journal of clinical oncology 43 (6), 452-455, 2020 | 431 | 2020 |
| Evidence-based pharmaceutical care: The next chapter in pharmacy practice OM Al-Quteimat, AM Amer Saudi Pharmaceutical Journal 24 (4), 447-451, 2016 | 122 | 2016 |
| SARS-CoV-2 outbreak: how can pharmacists help? AMAR Ph Research in Social and Administrative Pharmacy 17 (2), 480-482, 2021 | 110 | 2021 |
| Methotrexate and trimethoprim–sulphamethoxazole: extremely serious and life‐threatening combination OM Al‐Quteimat, MA Al‐Badaineh Journal of clinical pharmacy and therapeutics 38 (3), 203-205, 2013 | 43 | 2013 |
| Valproate interaction with carbapenems: review and recommendations O Al-Quteimat, A Laila Hospital Pharmacy 55 (3), 181-187, 2020 | 36 | 2020 |
| Intraperitoneal chemotherapy: rationale, applications, and limitations OM Al-Quteimat, MA Al-Badaineh Journal of Oncology Pharmacy Practice 20 (5), 369-380, 2014 | 30 | 2014 |
| Practical issues with high dose methotrexate therapy OM Al-Quteimat, MA Al-Badaineh Saudi Pharmaceutical Journal 22 (4), 385-387, 2014 | 27 | 2014 |
| The impact of clinical pharmacist and ID intervention in rationalization of antimicrobial use N Al-Somai, M Al-Muhur, O Quteimat, N Hamzah Saudi Pharmaceutical Journal 22 (6), 516-521, 2014 | 23 | 2014 |
| Phenytoin-induced toxic epidermal necrolysis: Review and recommendations OM Al-Quteimat Journal of Pharmacology and Pharmacotherapeutics 7 (3), 127-132, 2016 | 16 | 2016 |
| Incorporating a clinical oncology pharmacist into an ambulatory care pharmacy in pediatric hematology–oncology and transplant clinic: Assessment and significance K Ali, O Al-Quteimat, R Naseem, SM Malhi, M Wajdi, N Jahan, SH Ansari, ... Journal of Oncology Pharmacy Practice 27 (4), 815-820, 2021 | 11 | 2021 |
| A review of osimertinib in NSCLC and pharmacist role in NSCLC patient care OM Al-Quteimat, AM Amer Journal of Oncology Pharmacy Practice 26 (6), 1452-1460, 2020 | 9 | 2020 |
| Analysis of pharmacist interventions in adult COVID-19 patients admitted to a tertiary care hospital O Al-Quteimat, M Siddiqui, L Hussein, H Al Emleh, IELD Shamieh Journal of Pharmacy Practice 36 (3), 572-578, 2023 | 8 | 2023 |
| Role of oncology clinical pharmacist: a case of life-saving interventions OM Al-Quteimat, MA Al-Badaineh Int J Basic Clin Pharmacol 2, 655-658, 2013 | 7 | 2013 |
| Olanzapine for Prevention or Management of Chemotherapy-Induced Nausea and Vomiting: A Promising Option. O Al-Quteimat, J Tollison, MA Siddiqui Journal of Hematology Oncology Pharmacy 9 (1), 2019 | 2 | 2019 |
| The strategic role of healthcare professionals in the battle against COVID-19: do we really need help from community pharmacists? K Ali, M Wajdi, O Al Quteimat J Coll Physicians Surg Pak 31 (7), S109-S111, 2021 | 1 | 2021 |
| Vincristine Shortage: What Other Options We Have? OM Al-Quteimat American Journal of Clinical Oncology 43 (2), 146-147, 2020 | 1 | 2020 |
| 1189. The Impact of Clinical Staff Pharmacist Driven Weekend Antimicrobial Stewardship Coverage in a Quaternary Hospital in UAE H Elrefaei, O Al Quteimat, R Ismail, R Nasef, M Hisham, WS El Nekidy, ... Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 1029, 2023 | | 2023 |
| Hematology Oncology Patients’ Care in a Pandemic Situation of COVID-19: Where Do We Stand? K Ali, M Wajdi, O Al-Quteimat Hospital Pharmacy 56 (6), 622-623, 2021 | | 2021 |
